Lybrido(s) and SSRIs @Home: A double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction in combination with SSRI use.

Trial Profile

Lybrido(s) and SSRIs @Home: A double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction in combination with SSRI use.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Buspirone/testosterone (Primary) ; Sildenafil/testosterone (Primary) ; Serotonin uptake inhibitors
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Acronyms @HOME; AT-HOME
  • Sponsors Emotional Brain
  • Most Recent Events

    • 21 Sep 2009 Status changed from recruiting to completed as reported by Netherlands Trial Register record.
    • 14 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top